BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• CardioMetabolics Shareholders Approve Change in Company’s Name to Valens Pharma Ltd.

  July 3, 2008

   · 

  1 min read
• Deals

  ZONARE Medical Systems, Inc. Files Registration Statement for Initial Public Offering

  July 3, 2008

   · 

  2 min read
• Drug Development

  Skyepharma PLC Phase 3 FlutiformTM Study Meets Primary Endpoints

  July 3, 2008

   · 

  4 min read
• Pharm Country

  Pulmo BioTech Announces Possibility of MRI Application for PulmoBind

  July 3, 2008

   · 

  4 min read
• Pharm Country

  MedaSorb Technologies Raises $4.45 Million; Funds to Be Used for Current Sepsis Clinical Study and to Prepare for CE Mark Application

  July 3, 2008

   · 

  4 min read
• Vasogen Implements Additional Restructuring

  July 3, 2008

   · 

  2 min read
• Business

  Paladin Labs Inc. and Procter & Gamble Pharmaceuticals, Inc. Enter Into Canadian Co-Promotion Agreement for Seasonale(TM): First and Only Extended-Cycle Oral Contraceptive Available in Canada

  July 3, 2008

   · 

  1 min read
• Business

  Senetek PLC Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Ltd.

  July 3, 2008

   · 

  2 min read
• BioForest

  BioCurex Inc. Comments On Market Activity

  July 3, 2008

   · 

  1 min read
• Drug Development

  RegeneRx Biopharmaceuticals, Inc. Completes Enrollment and Dosing of Phase IA Safety Trial for Potential Heart Drug

  July 3, 2008

   · 

  1 min read